GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » ROA %

CELZ (Creative Medical Technology Holdings) ROA % : -87.27% (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Creative Medical Technology Holdings's annualized Net Income for the quarter that ended in Mar. 2025 was $-6.55 Mil. Creative Medical Technology Holdings's average Total Assets over the quarter that ended in Mar. 2025 was $7.51 Mil. Therefore, Creative Medical Technology Holdings's annualized ROA % for the quarter that ended in Mar. 2025 was -87.27%.

The historical rank and industry rank for Creative Medical Technology Holdings's ROA % or its related term are showing as below:

CELZ' s ROA % Range Over the Past 10 Years
Min: -5816.65   Med: -624.09   Max: 320.57
Current: -77.06

During the past 13 years, Creative Medical Technology Holdings's highest ROA % was 320.57%. The lowest was -5816.65%. And the median was -624.09%.

CELZ's ROA % is ranked worse than
77.47% of 1487 companies
in the Biotechnology industry
Industry Median: -31.6 vs CELZ: -77.06

Creative Medical Technology Holdings ROA % Historical Data

The historical data trend for Creative Medical Technology Holdings's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings ROA % Chart

Creative Medical Technology Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,816.65 320.57 -66.62 -35.36 -63.20

Creative Medical Technology Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.99 -70.78 -55.92 -109.40 -87.27

Competitive Comparison of Creative Medical Technology Holdings's ROA %

For the Biotechnology subindustry, Creative Medical Technology Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Medical Technology Holdings's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's ROA % distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's ROA % falls into.


;
;

Creative Medical Technology Holdings ROA % Calculation

Creative Medical Technology Holdings's annualized ROA % for the fiscal year that ended in Dec. 2024 is calculated as:

ROA %=Net Income (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=-5.493/( (10.715+6.669)/ 2 )
=-5.493/8.692
=-63.20 %

Creative Medical Technology Holdings's annualized ROA % for the quarter that ended in Mar. 2025 is calculated as:

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=-6.552/( (6.669+8.347)/ 2 )
=-6.552/7.508
=-87.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data. ROA % is displayed in the 30-year financial page.


Creative Medical Technology Holdings  (NAS:CELZ) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2025 )
=Net Income/Total Assets
=-6.552/7.508
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.552 / 0.012)*(0.012 / 7.508)
=Net Margin %*Asset Turnover
=-54600 %*0.0016
=-87.27 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) net income data. The Revenue data used here is four times the quarterly (Mar. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Creative Medical Technology Holdings ROA % Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings Business Description

Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Michael H. Finger director 1551 N. DIANE ST., MESA AZ 85203-3850
Timothy Warbington director, 10 percent owner, officer: President & CEO 211 E. OSBORN ROAD, PHOENIX AZ 85012
Susan H Snow director 26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang director 5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim director 211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc. 10 percent owner 211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst 10 percent owner 2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel director 1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson director, officer: CFO & Sr.VP 822 VERA STREET, SOLANA BEACH CA 92075
Steven L White director, officer: President,Secretary,Treasurer 386 NORTH 210 EAST, MAPLETON UT 84664

Creative Medical Technology Holdings Headlines

From GuruFocus

Creative Medical Technology Holdings Provides Corporate Update

By PRNewswire PRNewswire 06-12-2023